Dental Suction Systems Market Growth & Trends:
The global dental suction systems market size is expected to reach USD 707.0 million by 2030, expanding at a CAGR of 4.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growth is attributable to technological advancements in dental suction products. Moreover, an increasing number of dental surgical procedures is expected to contribute to the growth of the market. Technological advancements are also expected to favor market growth. For instance, Tyscor, a new suction unit, is energy-efficient and saves more than 50% of energy. The device is also lightweight & compact and it can convert the dry suction unit to a wet suction unit. In addition, the device is the first spray mist suction unit with radial technology in the dental market.
The patients and dental staff are at high risk to get infected by the spread of harmful aerosols that are generated during dental procedures. Many people during the COVID-19 pandemic actively avoided visiting hospitals and dental clinics frequently to protect themselves from getting infected by the coronavirus. According to the Agency for Healthcare Research and Quality, in August 2020, the outbreak of coronavirus disease in 2019 had led to the closure of approximately 198,000 active dental specialists and dentists' offices in the U.S. This has reduced the number of dental procedures and affected the overall market.
Dental Suction Systems Market Report Highlights:
- Instruments held the largest market, whereas FISH imaging services are expected to grow at the fastest rate during the forecast period
- At present, the market penetration of FISH imaging in cancer diagnostics is very high, hence the diagnostic laboratories segment accounted for larger revenues
- Cancer diagnosis held the largest revenue share owing to increasing incidence of cancer, thus fueling the adoption of FISH imaging systems
- Among end-use segments, companion diagnostics is expected to witness faster growth than research and diagnostic segments
- Diagnostic laboratories held the dominant position in 2016 as these systems are predominantly used in various clinical studies for visualization of precancerous lesions in cervical cancer, assessing the risk of human papillomavirus, and for detection of leukemia, myelodysplastic syndrome, multiple myeloma, & chromosomal abnormalities
- North America held the largest revenue share owing to extensive adoption of these solutions in research and development across this region
- Asia Pacific is anticipated to exhibit lucrative CAGR over the forecast period due to the increase in investments by manufacturers & governments, supportive government initiatives in the biotechnology sector, and the presence of a large number of untapped opportunities
- The industry is highly competitive with a limited number of players holding a majority of the overall revenues. Some of the most notable market participants are Euroclone SpA, TissueGnostics GmbH, Agilent Technologies, Inc., Abnova Taiwan Corp, BioGenex Laboratories Inc., o Bio-View Ltd and General Electric Company. They account for a considerable share of the industry